Pacritinib to treat myelofibrosis patients with thrombocytopenia

Tremblay, D; Mascarenhas, J

Mascarenhas, J (reprint author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, One Gustave L Levy Pl Box 1079, New York, NY 10029 USA.

EXPERT REVIEW OF HEMATOLOGY, 2018; 11 (9): 707

Abstract

Introduction: Treatment with ruxolitinib, a selective JAK1/2 inhibitor, has significantly improved the lives of patients with myelofibrosis. Unfortuna......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索